4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-036261
EVP, Chief Accounting Officer gave up 12,132 shares (to pay taxes)
- EVP, Chief Accounting Officer acquired 41,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster Wayne EVP, Chief Accounting Officer | 2026-01-31 | Option exercise | +41,333 | 91,461 | D | ||
| Foster Wayne EVP, Chief Accounting Officer | 2026-01-31 | Shares withheld for taxes | −12,132 | $4.24 | $51,440 | 79,329 | D |
| Derivatives | |||||||
| Foster Wayne EVP, Chief Accounting Officer | 2026-01-31 | Option exercise · Restricted Stock Units | −33,333 | 0 | D | ||
| Foster Wayne EVP, Chief Accounting Officer | 2026-01-31 | Option exercise · Restricted Stock Units | −8,000 | 0 | D | ||
| Foster Wayne EVP, Chief Accounting Officer | 2026-01-31 | Grant or award · Stock Option (Right to Buy) | +108,000 | 108,000 | D | ||
Loading xslF345X05/ownership.xml…